Your WeeklyPaper Digest — 3 new papers · January 1, 2026 (Example)
 ‌​‍‎‏ ‌​‍‎‏ ‌​‍‎‏ ‌​‍‎‏ ‌​‍‎‏ ‌​‍‎‏ ‌​‍‎‏ ‌​‍‎‏ ‌​‍‎‏ ‌​‍‎‏ ‌​‍‎‏ ‌​‍‎‏ ‌​‍‎‏ ‌​‍‎‏ ‌​‍‎‏ ‌​‍‎‏ ‌​‍‎‏ ‌​‍‎‏ ‌​‍‎‏ ‌​‍‎‏ ‌​‍‎‏ ‌​‍‎‏ ‌​‍‎‏ ‌​‍‎‏ ‌​‍‎‏ ‌​‍‎‏ ‌​‍‎‏ ‌​‍‎‏ ‌​‍‎‏ ‌​‍‎‏ ‌​‍‎‏ ‌​‍‎‏ ‌​‍‎‏ ‌​‍‎‏ ‌​‍‎‏ ‌​‍‎‏ ‌​‍‎‏ ‌​‍‎‏ ‌​‍‎‏ ‌​‍‎‏ ‌​‍‎‏ ‌​‍‎‏ ‌​‍‎‏ ‌​‍‎‏ ‌​‍‎‏ ‌​‍‎‏ ‌​‍‎‏ ‌​‍‎‏ ‌​‍‎‏ ‌​‍‎‏ ‌​‍‎‏ ‌​‍‎‏ ‌​‍‎‏ ‌​‍‎‏ ‌​‍‎‏ ‌​‍‎‏ ‌​‍‎‏ ‌​‍‎‏ ‌​‍‎‏ ‌​‍‎‏ ‌​‍‎‏ ‌​‍‎‏ ‌​‍‎‏ ‌​‍‎‏ ‌​‍‎‏ ‌​‍‎‏ ‌​‍‎‏ ‌​‍‎‏ ‌​‍‎‏ ‌​‍‎‏ ‌​‍‎‏ ‌​‍‎‏ ‌​‍‎‏ ‌​‍‎‏ ‌​‍‎‏ ‌​‍‎‏ ‌​‍‎‏ ‌​‍‎‏ ‌​‍‎‏ ‌​‍‎‏ ‌​‍‎‏ ‌​‍‎‏ ‌​‍‎‏ ‌​‍‎‏

·

WeeklyPaper

Research Digest

January 1, 2026 (Example)

3 papers

01

[Example] Machine Learning-Based Prediction of Heart Failure Outcomes in Elderly Patients

Example Journal of Cardiology · 2026 Jan

Example A, Example B, Example C

A fictional gradient boosting model achieves AUC 0.82 for 30-day readmission prediction.

⚠️ This is a fictional example for illustration purposes only. In this hypothetical study, a machine learning model was developed to predict 30-day readmission risk in elderly heart failure patients using EHR data from 12,000 fictional patients across 8 hospitals. The gradient boosting model achieved an AUC of 0.82, outperforming traditional scoring systems. Key predictors included BNP levels, renal function, and prior hospitalization frequency.

Key Points

▸ Fictional gradient boosting model achieved AUC 0.82 for 30-day readmission prediction

▸ BNP and renal function were the strongest predictors in this example

▸ Model validated across 8 fictional external hospital cohorts

View on PubMed →☆ Bookmark

02

[Example] SGLT2 Inhibitor Use and Cardiovascular Outcomes: A Large-Scale Real-World Analysis

Example Journal of Internal Medicine · 2026 Jan

Example D, Example E

In this fictional cohort, SGLT2 inhibitors reduce MACE by 23% compared to DPP-4 inhibitors.

⚠️ This is a fictional example for illustration purposes only. A hypothetical retrospective cohort study of 45,000 fictional type 2 diabetes patients found that SGLT2 inhibitor use was associated with a 23% reduction in major adverse cardiovascular events compared to DPP-4 inhibitors. The benefit was consistent across age groups but was most pronounced in patients with established cardiovascular disease.

Key Points

▸ 23% reduction in MACE with SGLT2 inhibitors vs DPP-4 inhibitors (fictional data)

▸ Greatest benefit in patients with existing cardiovascular disease

▸ Effect consistent across age subgroups in this example

View on PubMed →☆ Bookmark

03

[Example] Deep Learning for Automated Echocardiographic Assessment of Left Ventricular Function

Example European Heart Journal · 2026 Jan

Example F, Example G, Example H

A fictional CNN trained on 50,000 echocardiograms matches cardiologist accuracy for EF measurement.

⚠️ This is a fictional example for illustration purposes only. A hypothetical convolutional neural network trained on 50,000 fictional echocardiograms achieved cardiologist-level accuracy in measuring ejection fraction, with a mean absolute error of 3.8%. The model demonstrated robust performance across different ultrasound machines and operator skill levels.

Key Points

▸ Fictional CNN achieved MAE of 3.8% for ejection fraction measurement

▸ Performance equivalent to expert cardiologist assessment in this example

▸ Robust across multiple ultrasound vendors and operator skill levels

View on PubMed →☆ Bookmark

WeeklyPaper · Automated research digest

Summaries and key points are AI-generated and may contain errors or omissions. Always verify findings against the original publication before clinical or research use.

You're receiving this because you subscribed to weekly paper digests. Unsubscribe